Hospital And Nursing Home Probiotics Global Market Report 2025

Description

Hospital and nursing home probiotics are dietary supplements containing live microorganisms, typically beneficial bacteria, that provide health benefits when consumed in adequate amounts. These probiotics are particularly valuable for supporting digestive health, boosting immune function, and improving general wellbeing, especially for vulnerable populations such as the elderly and patients with weakened immune systems.

The primary indications for using probiotics in hospital and nursing home settings include conditions such as antibiotic-associated diarrhea, irritable bowel syndrome (IBS), Clostridium difficile infection, inflammatory bowel disease (IBD), and general gut health maintenance. Antibiotic-associated diarrhea, in particular, is a common issue resulting from the disruption of gut microbiota due to antibiotics, and probiotics are often used to restore balance and alleviate symptoms. Probiotics come in various formulations, including capsules, powders, liquids, soft chews, and probiotic yogurt, allowing for flexible administration tailored to the needs of different patient groups, such as infants, adults, the elderly, immunocompromised patients, and those with gastrointestinal disorders. These products are distributed through a variety of channels, including hospitals, nursing homes, pharmacies, online retail, and healthcare facilities, and they are used primarily in areas related to gut health, immunity, and overall wellness.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The hospital and nursing home probiotics market research report is one of a series of new reports from The Business Research Company that provides hospital and nursing home probiotics market statistics, including the hospital and nursing home probiotics industry global market size, regional shares, competitors with the hospital and nursing home probiotics market share, detailed hospital and nursing home probiotics market segments, market trends, and opportunities, and any further data you may need to thrive in the hospital and nursing home probiotics industry. This hospital and nursing home probiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hospital and nursing home probiotics market size has grown rapidly in recent years. It will grow from $1.51 billion in 2024 to $1.69 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to increasing awareness of gut health, rising prevalence of gastrointestinal disorders, increasing adoption of probiotics in healthcare settings, growing evidence supporting the health benefits of probiotics.

The hospital and nursing home probiotics market size is expected to see rapid growth in the next few years. It will grow to $2.58 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to increasing adoption of probiotics, rising demand for digestive health solutions, growing awareness of probiotics, rising focus on reducing hospital-acquired infections (HAIs), growing investments in probiotic-based medical nutrition. Major trends in the forecast period include advancements in probiotic formulations, improvements in delivery methods for targeted healthcare settings, innovations in probiotics for infection prevention, development of specialized probiotics for elderly and immunocompromised patients, and integration of digital solutions.

The forecast of 11.3% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. healthcare facilities by driving up the cost of medical-grade probiotics for gut health and infection prevention sourced from Japan and Denmark, exacerbating long-term care facility budgets and limiting patient access. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of gastrointestinal disorders is expected to drive the expansion of the hospital and nursing home probiotics market. These disorders encompass various conditions affecting the digestive system, such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and constipation. The rise in these conditions is linked to factors such as unhealthy eating habits, a higher intake of processed foods, sedentary lifestyles, and elevated stress levels. Probiotics used in hospitals and nursing homes help manage gastrointestinal disorders by restoring the balance of beneficial bacteria in the gut, improving digestive health, and alleviating symptoms such as diarrhea, constipation, and bloating. For example, in December 2023, the IBD Registry, a UK-based non-profit organization, reported that the number of people with inflammatory bowel disease (IBD) surpassed 5,300 by 2023, an increase of more than 3,000 individuals compared to 2022. As a result, the rising incidence of gastrointestinal disorders is contributing to the growth of the hospital and nursing home probiotics market.

Companies operating in the hospital and nursing home probiotics market are focusing on creating innovative products such as probiotic solutions to enhance gut health, accelerate recovery, and minimize side effects associated with antibiotics. Probiotic solutions contain live microorganisms that offer health benefits when consumed in sufficient quantities, typically by improving the balance of good bacteria in the digestive system. For example, in October 2024, Probi AB, a biotechnology company from Sweden, launched "Metabolic Health by Probi" for healthcare environments. This clinically supported probiotic solution combines two proprietary strains, Lactiplantibacillus plantarum 299v (LP299V) and Lacticaseibacillus paracasei 8700:2 (L. Paracasei 8700:2), to promote metabolic health, cardiovascular well-being, weight management, and blood pressure regulation.

In June 2023, Clasado Limited, a UK-based biotechnology firm, collaborated with Probi AB to further develop synbiotic products targeting gut health. The partnership aims to combine their expertise to advance the development and commercialization of scientifically supported synbiotics, which offer specific health benefits for consumers. Probi AB, based in Sweden, specializes in the development and commercialization of probiotic products backed by scientific research, preclinical studies, and clinical trials.

Major players in the hospital and nursing home probiotics market are Nestle Health Science, BASF SE, Procter & Gamble Company, Abbott Laboratories, Lactalis Group, Danone S.A., General Mills Inc., Arla Foods, DuPont de Nemours Inc., Kerry Group plc, Koninklijke DSM N.V., Glanbia PLC, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., BioGaia AB, Klaire Labs, SymbioPharm GmbH, Synlogic Inc., Vitakem Nutraceuticals.

North America was the largest region in the hospital and nursing home probiotics market in 2024. The regions covered in hospital and nursing home probiotics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hospital and nursing home probiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hospital and nursing home probiotics market includes revenues earned by entities by sales of probiotic-infused wound care products, probiotic-infused foods, and medical-grade probiotics and related services such as probiotic therapy and consultation, infection control and prevention, probiotic supplementation programs, and probiotic administration monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hospital And Nursing Home Probiotics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hospital and nursing home probiotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hospital and nursing home probiotics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hospital and nursing home probiotics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Indication: Antibiotic-Associated Diarrhea; Irritable Bowel Syndrome; Clostridium difficile Infection; Inflammatory Bowel Disease; General Gut Health
2) By Formulation Type: Capsules; Powder; Liquid; Soft Chew; Probiotic Yogurt
3) By Patient Group: Infants; Adults; Elderly; Immunocompromised Patients; Patients With Gastrointestinal Disorders
4) By Distribution Channel: Hospitals; Nursing Homes; Pharmacies; Online Retail; Healthcare Facilities
5) By Application: Gut Health; Immunity; Wellness; Other Applications
Subsegments:
1) By Antibiotic-Associated Diarrhea (AAD): Prevention of AAD; Treatment of AAD
2) By Irritable Bowel Syndrome (IBS): IBS With Diarrhea (IBS-D); IBS With Constipation (IBS-C); Mixed IBS (IBS-M)
3) By Clostridium Difficile Infection (CDI): Prevention of CDI Recurrence; Treatment Of CDI
4) By Inflammatory Bowel Disease (IBD): Crohn's Disease; Ulcerative Colitis
5) By General Gut Health: Immune System Support; Digestive Health; Gut Microbiome Restoration
Companies Mentioned: Nestle Health Science; BASF SE; Procter & Gamble Company; Abbott Laboratories; Lactalis Group; Danone S.A.; General Mills Inc.; Arla Foods Group; DuPont de Nemours Inc.; Kerry Group plc; Koninklijke DSM N.V.; Glanbia PLC; Yakult Honsha Co. Ltd.; Chr. Hansen Holding A/S; Lallemand Inc.; BioGaia AB; Klaire Labs; SymbioPharm GmbH; Synlogic Inc.; Vitakem Nutraceuticals
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r33764u

1. Executive Summary

2. Hospital And Nursing Home Probiotics Market Characteristics

3. Hospital And Nursing Home Probiotics Market Trends And Strategies

4. Hospital And Nursing Home Probiotics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hospital And Nursing Home Probiotics Growth Analysis And Strategic Analysis Framework

5.1. Global Hospital And Nursing Home Probiotics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Hospital And Nursing Home Probiotics Market Growth Rate Analysis
5.4. Global Hospital And Nursing Home Probiotics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Hospital And Nursing Home Probiotics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Hospital And Nursing Home Probiotics Total Addressable Market (TAM)

6. Hospital And Nursing Home Probiotics Market Segmentation

6.1. Global Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antibiotic-Associated Diarrhea
Irritable Bowel Syndrome
Clostridium difficile Infection
Inflammatory Bowel Disease
General Gut Health
6.2. Global Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Capsules
Powder
Liquid
Soft Chew
Probiotic Yogurt
6.3. Global Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infants
Adults
Elderly
Immunocompromised Patients
Patients With Gastrointestinal Disorders
6.4. Global Hospital And Nursing Home Probiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Nursing Homes
Pharmacies
Online Retail
Healthcare Facilities
6.5. Global Hospital And Nursing Home Probiotics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gut Health
Immunity
Wellness
Other Applications
6.6. Global Hospital And Nursing Home Probiotics Market, Sub-Segmentation Of Antibiotic-Associated Diarrhea (AAD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prevention of AAD
Treatment of AAD
6.7. Global Hospital And Nursing Home Probiotics Market, Sub-Segmentation Of Irritable Bowel Syndrome (IBS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
IBS With Diarrhea (IBS-D)
IBS With Constipation (IBS-C)
Mixed IBS (IBS-M)
6.8. Global Hospital And Nursing Home Probiotics Market, Sub-Segmentation Of Clostridium Difficile Infection (CDI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prevention of CDI Recurrence
Treatment Of CDI
6.9. Global Hospital And Nursing Home Probiotics Market, Sub-Segmentation Of Inflammatory Bowel Disease (IBD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Crohn's Disease
Ulcerative Colitis
6.10. Global Hospital And Nursing Home Probiotics Market, Sub-Segmentation Of General Gut Health, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immune System Support
Digestive Health
Gut Microbiome Restoration

7. Hospital And Nursing Home Probiotics Market Regional And Country Analysis

7.1. Global Hospital And Nursing Home Probiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Hospital And Nursing Home Probiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hospital And Nursing Home Probiotics Market

8.1. Asia-Pacific Hospital And Nursing Home Probiotics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hospital And Nursing Home Probiotics Market

9.1. China Hospital And Nursing Home Probiotics Market Overview
9.2. China Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hospital And Nursing Home Probiotics Market

10.1. India Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hospital And Nursing Home Probiotics Market

11.1. Japan Hospital And Nursing Home Probiotics Market Overview
11.2. Japan Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hospital And Nursing Home Probiotics Market

12.1. Australia Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hospital And Nursing Home Probiotics Market

13.1. Indonesia Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hospital And Nursing Home Probiotics Market

14.1. South Korea Hospital And Nursing Home Probiotics Market Overview
14.2. South Korea Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hospital And Nursing Home Probiotics Market

15.1. Western Europe Hospital And Nursing Home Probiotics Market Overview
15.2. Western Europe Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hospital And Nursing Home Probiotics Market

16.1. UK Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hospital And Nursing Home Probiotics Market

17.1. Germany Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hospital And Nursing Home Probiotics Market

18.1. France Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hospital And Nursing Home Probiotics Market

19.1. Italy Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hospital And Nursing Home Probiotics Market

20.1. Spain Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hospital And Nursing Home Probiotics Market

21.1. Eastern Europe Hospital And Nursing Home Probiotics Market Overview
21.2. Eastern Europe Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hospital And Nursing Home Probiotics Market

22.1. Russia Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hospital And Nursing Home Probiotics Market

23.1. North America Hospital And Nursing Home Probiotics Market Overview
23.2. North America Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hospital And Nursing Home Probiotics Market

24.1. USA Hospital And Nursing Home Probiotics Market Overview
24.2. USA Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hospital And Nursing Home Probiotics Market

25.1. Canada Hospital And Nursing Home Probiotics Market Overview
25.2. Canada Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hospital And Nursing Home Probiotics Market

26.1. South America Hospital And Nursing Home Probiotics Market Overview
26.2. South America Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hospital And Nursing Home Probiotics Market

27.1. Brazil Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hospital And Nursing Home Probiotics Market

28.1. Middle East Hospital And Nursing Home Probiotics Market Overview
28.2. Middle East Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hospital And Nursing Home Probiotics Market

29.1. Africa Hospital And Nursing Home Probiotics Market Overview
29.2. Africa Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hospital And Nursing Home Probiotics Market Competitive Landscape And Company Profiles

30.1. Hospital And Nursing Home Probiotics Market Competitive Landscape
30.2. Hospital And Nursing Home Probiotics Market Company Profiles
- 30.2.1. Nestle Health Science Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. BASF SE Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Procter & Gamble Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Lactalis Group Overview, Products and Services, Strategy and Financial Analysis

31. Hospital And Nursing Home Probiotics Market Other Major And Innovative Companies

31.1. Danone S.A.
31.2. General Mills Inc.
31.3. Arla Foods Group
31.4. DuPont de Nemours Inc.
31.5. Kerry Group plc
31.6. Koninklijke DSM N.V.
31.7. Glanbia PLC
31.8. Yakult Honsha Co. Ltd.
31.9. Chr. Hansen Holding A/S
31.10. Lallemand Inc.
31.11. BioGaia AB
31.12. Klaire Labs
31.13. SymbioPharm GmbH
31.14. Synlogic Inc.
31.15. Vitakem Nutraceuticals

32. Global Hospital And Nursing Home Probiotics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hospital And Nursing Home Probiotics Market

34. Recent Developments In The Hospital And Nursing Home Probiotics Market

35. Hospital And Nursing Home Probiotics Market High Potential Countries, Segments and Strategies

35.1 Hospital And Nursing Home Probiotics Market In 2029 - Countries Offering Most New Opportunities
35.2 Hospital And Nursing Home Probiotics Market In 2029 - Segments Offering Most New Opportunities
35.3 Hospital And Nursing Home Probiotics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer